Search Tag: Roche
2021 03 Dec
Roche announced that at its December meeting the Board of Directors of Roche Holding Ltd has approved first proposals to the Annual General Meeting (AGM) scheduled for 15 March 2022. Mr Paul Bulcke, who has been serving on the Board of Directors since 2011, has decided not to stand for re-election at the AGM in 2022, following almost eleven years...Read more
2021 20 Oct
Diabetes is a chronic disease that requires daily management including lifestyle and behavioural modifications, compliance with medications, blood glucose control and close patient monitoring, all of which can be efficiently supported by digital solutions. Diabetes is a global health crisis. Recent estimates suggest the incidence of diabetes...Read more
2019 01 Jul
The medical diagnostic company BioPorto has recently announced that it will be introducing Christopher Bird as the new Chief Medical Officer. Bird joins BioPorto from his role at Roche Diagnostics as Head of Medical and Scientific Affairs in North America. After over 10 years with this medical and scientific affairs organisation, Christopher will...Read more
2016 20 Jan
As the debate and uncertainties regarding Pharma and Social Media continue to heighten, SMi are once again, kicking off the brand new year with this highly engaging and innovative event. Social media, being the prime location for global conversations plays a central role in pharma covigilance and digital marketing, as well as understanding trends,...Read more
2015 29 Jun
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced that its improved CARDIAC point-of-care Troponin T test for the cobas h 232 system is now available for countries accepting the CE Mark*. The test allows healthcare professionals to identify patients with a suspected acute myocardial infarction (AMI), termed also heart attack, with greater accuracy at...Read more
2014 06 Oct
At the most recent European Society of Oncology meeting in Madrid, the results for the CLEOPATRA breast cancer study on Roche's Perjeta (pertuzumab) were presented. The results were declared to be extraordinary and unprecedented. “Many of us work our whole career to have this kind of data,” said Sandra Swain, medical director of the Washington...Read more
2014 28 Jan
Roche Diagnostics Middle East launches the region’s first comprehensive Roche Blood Safety Solution (RBSS) portfolio at Arab Health • The only comprehensive RBSS portfolio of serology screening solutions and nucleic acid testing (NAT) available in the Middle East from a single source • RBSS safeguards patients through industry-leading assays...Read more
2013 18 Jul
New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu Roche today announced the global launch (except US) of Elecsys ProGRP, a test that distinguishes between the two main types of lung cancer – small cell (SCLC) and non-small cell (NSCLC) lung cancer – and can help diagnose early-stage...Read more